251 related articles for article (PubMed ID: 10676649)
1. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma.
Xu G; Pan J; Martin C; Yeung SC
J Clin Endocrinol Metab; 2001 Apr; 86(4):1769-77. PubMed ID: 11297616
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy including combretastatin A4 phosphate and paclitaxel is effective against anaplastic thyroid cancer in a nude mouse xenograft model.
Yeung SC; She M; Yang H; Pan J; Sun L; Chaplin D
J Clin Endocrinol Metab; 2007 Aug; 92(8):2902-9. PubMed ID: 17550961
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel.
Pan J; Xu G; Yeung SC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4731-40. PubMed ID: 11600533
[TBL] [Abstract][Full Text] [Related]
5. p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells.
Yang HL; Pan JX; Sun L; Yeung SC
J Clin Endocrinol Metab; 2003 Feb; 88(2):763-72. PubMed ID: 12574211
[TBL] [Abstract][Full Text] [Related]
6. Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model.
She M; Jim Yeung SC
Cancer Lett; 2006 Jul; 238(2):197-201. PubMed ID: 16154259
[TBL] [Abstract][Full Text] [Related]
7. Modulation of parathyroid hormone-related protein levels (PTHrP) in anaplastic thyroid cancer.
Dackiw A; Pan J; Xu G; Yeung SC
Surgery; 2005 Sep; 138(3):456-63. PubMed ID: 16213899
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2-associated X protein is the main mediator of manumycin a-induced apoptosis in anaplastic thyroid cancer cells.
Pan J; Huang H; Sun L; Fang B; Yeung SC
J Clin Endocrinol Metab; 2005 Jun; 90(6):3583-91. PubMed ID: 15769983
[TBL] [Abstract][Full Text] [Related]
9. [Effects of manumycin combined with methoxyamine on apoptosis in myeloid leukemia U937 cells].
She MR; Guo KY; Niu XQ; Lu XX
Ai Zheng; 2008 Aug; 27(8):835-9. PubMed ID: 18710617
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.
Di Paolo A; Danesi R; Caputo S; Macchia M; Lastella M; Boggi U; Mosca F; Marchetti A; Del Tacca M
Br J Cancer; 2001 Jun; 84(11):1535-43. PubMed ID: 11384105
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo.
Ain KB; Tofiq S; Taylor KD
J Clin Endocrinol Metab; 1996 Oct; 81(10):3650-3. PubMed ID: 8855817
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of manumycin A-induced apoptosis by methoxyamine in myeloid leukemia cells.
She M; Pan I; Sun L; Yeung SC
Leukemia; 2005 Apr; 19(4):595-602. PubMed ID: 15744347
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
Hu W; Wu W; Yeung SC; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2002; 22(2A):665-72. PubMed ID: 12014635
[TBL] [Abstract][Full Text] [Related]
15. 2-methoxyestradiol induces apoptosis in cultured human anaplastic thyroid carcinoma cells.
Roswall P; Bu S; Rubin K; Landström M; Heldin NE
Thyroid; 2006 Feb; 16(2):143-50. PubMed ID: 16676399
[TBL] [Abstract][Full Text] [Related]
16. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.
Kim S; Prichard CN; Younes MN; Yazici YD; Jasser SA; Bekele BN; Myers JN
Clin Cancer Res; 2006 Jan; 12(2):600-7. PubMed ID: 16428506
[TBL] [Abstract][Full Text] [Related]
18. ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines.
Portella G; Scala S; Vitagliano D; Vecchio G; Fusco A
J Clin Endocrinol Metab; 2002 Jun; 87(6):2525-31. PubMed ID: 12050209
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.
Gomez-Rivera F; Santillan-Gomez AA; Younes MN; Kim S; Fooshee D; Zhao M; Jasser SA; Myers JN
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4519-27. PubMed ID: 17671138
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
